Hepatitis C-related knowledge and attitude among adults on probation in a large US city.

IF 3 Q1 CRIMINOLOGY & PENOLOGY Health and Justice Pub Date : 2024-07-11 DOI:10.1186/s40352-024-00287-4

Matthew S Minturn, Kevin F Kamis, David L Wyles, Tracy Scott, Hermione Hurley, Scott J Prendergast, Sarah E Rowan

{"title":"Hepatitis C-related knowledge and attitude among adults on probation in a large US city.","authors":"Matthew S Minturn, Kevin F Kamis, David L Wyles, Tracy Scott, Hermione Hurley, Scott J Prendergast, Sarah E Rowan","doi":"10.1186/s40352-024-00287-4","DOIUrl":null,"url":null,"abstract":"Background: Hepatitis C virus (HCV) continues to cause significant morbidity and mortality within the US, and disproportionately impacts those involved with the criminal justice system. Despite this, knowledge and attitudes regarding HCV treatment among adults on probation have not been well studied. We conducted a cross-sectional survey of adults on probation accessing on-site HCV testing and linkage services at the adult probation department in Denver, Colorado. The survey assessed general knowledge of HCV and HCV treatment, as well as attitudes surrounding HCV treatment that might reflect medical mistrust. We used bivariate and multivariable logistic regression to identify factors associated with previous HCV testing, previous HCV treatment, and HCV antibody positivity at the time the survey was conducted.Results: A total of 402 participants completed all or a portion of the survey. 69% of the participants were cis-gender men; 29% were white, 27% were Black, and 30% were Hispanic/Latinx. Fewer than half of participants correctly identified that HCV infection is commonly asymptomatic (46%), that there is currently no vaccine that prevents HCV (19%), and that reinfection after treatment is possible (47%). Very few participants felt that side-effects (9%) or cost of treatment (10%) were barriers to care. Many participants believed that racial disparities exist in the treatment of HCV (59%). The belief that people who use substances are treated inequitably by health care providers was also commonly reported (35% of participants). Self-reported injection drug use and higher HCV-related knowledge were positively associated with previous testing for HCV. Higher HCV-related knowledge was positively associated with HCV antibody positivity at the time of survey completion, though the magnitude of the association was small.Conclusion: Interventions are needed to increase knowledge of HCV, to improve access to HCV testing and treatment, and to reduce bias associated with HCV and substance use within the probation population.","PeriodicalId":37843,"journal":{"name":"Health and Justice","volume":null,"pages":null},"PeriodicalIF":3.0000,"publicationDate":"2024-07-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11238520/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Health and Justice","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1186/s40352-024-00287-4","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CRIMINOLOGY & PENOLOGY","Score":null,"Total":0}

引用次数: 0

Abstract

Background: Hepatitis C virus (HCV) continues to cause significant morbidity and mortality within the US, and disproportionately impacts those involved with the criminal justice system. Despite this, knowledge and attitudes regarding HCV treatment among adults on probation have not been well studied. We conducted a cross-sectional survey of adults on probation accessing on-site HCV testing and linkage services at the adult probation department in Denver, Colorado. The survey assessed general knowledge of HCV and HCV treatment, as well as attitudes surrounding HCV treatment that might reflect medical mistrust. We used bivariate and multivariable logistic regression to identify factors associated with previous HCV testing, previous HCV treatment, and HCV antibody positivity at the time the survey was conducted.

Results: A total of 402 participants completed all or a portion of the survey. 69% of the participants were cis-gender men; 29% were white, 27% were Black, and 30% were Hispanic/Latinx. Fewer than half of participants correctly identified that HCV infection is commonly asymptomatic (46%), that there is currently no vaccine that prevents HCV (19%), and that reinfection after treatment is possible (47%). Very few participants felt that side-effects (9%) or cost of treatment (10%) were barriers to care. Many participants believed that racial disparities exist in the treatment of HCV (59%). The belief that people who use substances are treated inequitably by health care providers was also commonly reported (35% of participants). Self-reported injection drug use and higher HCV-related knowledge were positively associated with previous testing for HCV. Higher HCV-related knowledge was positively associated with HCV antibody positivity at the time of survey completion, though the magnitude of the association was small.

Conclusion: Interventions are needed to increase knowledge of HCV, to improve access to HCV testing and treatment, and to reduce bias associated with HCV and substance use within the probation population.

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

美国一个大城市中被判缓刑的成年人对丙型肝炎的相关知识和态度。

背景：在美国，丙型肝炎病毒（HCV）继续导致严重的发病率和死亡率，并对刑事司法系统的相关人员造成了极大的影响。尽管如此，有关缓刑成年人对丙型肝炎病毒（HCV）治疗的认识和态度的研究还不够深入。我们在科罗拉多州丹佛市的成人缓刑部门对接受现场 HCV 检测和链接服务的缓刑成年人进行了一项横断面调查。该调查评估了有关 HCV 和 HCV 治疗的一般知识，以及围绕 HCV 治疗的态度，这些态度可能反映了对医疗的不信任。我们使用双变量和多变量逻辑回归来确定与既往 HCV 检测、既往 HCV 治疗以及调查时 HCV 抗体阳性相关的因素：共有 402 名参与者完成了全部或部分调查。69%的参与者为顺性性别男性；29%为白人，27%为黑人，30%为西班牙裔/拉丁裔。只有不到一半的参与者正确地指出，HCV 感染通常没有症状（46%），目前还没有预防 HCV 的疫苗（19%），以及治疗后可能再次感染（47%）。很少有参与者认为副作用（9%）或治疗费用（10%）是治疗的障碍。许多参与者认为在治疗 HCV 方面存在种族差异（59%）。认为医疗服务提供者不公平对待药物使用者的观点也很普遍（35% 的参与者）。自我报告的注射毒品使用情况和较高的 HCV 相关知识与之前的 HCV 检测呈正相关。较高的丙型肝炎病毒相关知识与完成调查时的丙型肝炎病毒抗体阳性率呈正相关，但相关程度较小：需要采取干预措施来增加对丙型肝炎病毒的了解，改善丙型肝炎病毒检测和治疗的可及性，并减少缓刑人群中与丙型肝炎病毒和药物使用相关的偏差。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文去求助

来源期刊

Health and Justice Social Sciences-Law

CiteScore

4.10

自引率

8.60%

发文量

审稿时长

13 weeks

期刊介绍： Health & Justice is open to submissions from public health, criminology and criminal justice, medical science, psychology and clinical sciences, sociology, neuroscience, biology, anthropology and the social sciences, and covers a broad array of research types. It publishes original research, research notes (promising issues that are smaller in scope), commentaries, and translational notes (possible ways of introducing innovations in the justice system). Health & Justice aims to: Present original experimental research on the area of health and well-being of people involved in the adult or juvenile justice system, including people who work in the system; Present meta-analysis or systematic reviews in the area of health and justice for those involved in the justice system; Provide an arena to present new and upcoming scientific issues; Present translational science—the movement of scientific findings into practice including programs, procedures, or strategies; Present implementation science findings to advance the uptake and use of evidence-based practices; and, Present protocols and clinical practice guidelines. As an open access journal, Health & Justice aims for a broad reach, including researchers across many disciplines as well as justice practitioners (e.g. judges, prosecutors, defenders, probation officers, treatment providers, mental health and medical personnel working with justice-involved individuals, etc.). The sections of the journal devoted to translational and implementation sciences are primarily geared to practitioners and justice actors with special attention to the techniques used.